13
Views
1
CrossRef citations to date
0
Altmetric
Articles

The Use of Fluorescence In Situ Hybridization in Diagnosing Pediatric Disorders

Pages 259-264 | Published online: 18 Jul 2013

References

  • Langer-Safer PR, Levine M, Ward DC: Immunological method for mapping genes on Drosophila polytene chromosomes. Paw Mui AccadUSA 79:4381–4385, 1982
  • Van Prooijen-Knegt AC, Van Hoek JF, Bauman JG, Van Duijn P, Wool IG, Van der Ploeg NI: In situ hybridization DNA sequences in human metaphase chromosomes sisualized by an indirect fluorescent immunocytochemical, procedure. EAT 'Cell Res 1412:397–407,1982
  • Pinkel D, Sh2aunle T, Gray JW: Cytogenetic analysis using quantitative, high-sensitivity, .fluorescence hybridization. Proc Nail Acad Sci USA 83:2934–2938, 1986
  • Pardue ML, Gall JG: Molecular hybridization of radioactive DNA to the DNA of cytological preparations. Proc Nall Acad Sci USA 64:600–604 1969.
  • Trask BJ: Human cytogenetics: 46 chromosomes, 46 year and counting. Nat Rev Genet 3:769–778,2002
  • Babu VR, Wiktor A: A fluorescence in situ hybridization tech-nique for retrospective cytogenetie analysis. Cjlogenet Cell Genet 57:16–17, 1991
  • Wiktor A, Puskorius R, Zubrickas K, Van Dyke DL: Sequen-tial G-banding and fluorescent in situ hybridization on periph-eral blood, bone marrow, and amniotic fluid samples. Am J Med Genet 79:38–41, 1998
  • Pauletti G, Dandekar S, Rong H, Ramos L, Peng H, Seshadri R, et al: Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immu-nohistochemistry. J Clin Oncol 18:3651–3664, 2000
  • Check W: Working out the kinks in HER2 testing. CAP Today 14:1, 2000
  • Qian J, Bostwick DG, Takahashi S, Borell TJ, Brown JA, Lieber MM, et al: Comparison of fluorescence in situ hybrid-ization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. Am J Pathol 149:1193–1199, 1996
  • Paternoster SF, Brockman SR, McClure RF, Remstein ED, Kurtin PJ, Dewald GW: A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using inter-phase fluorescence in situ hybridization. Am J Pathol 160: 1967–1972, 2002
  • Telenius H, Pelmear AH, Tunnacliffe A, Carter NP, Behmel A, Ferguson-Smith MA, et al: Cytogenetic analysis by chro-mosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer 4:257–263, 1992
  • Speicher MR, Gwyn Ballard S, Ward DC: Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 12:368–375, 1996
  • Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, et al: Multicolor spectral karyotyping of human chromosomes. Science 273:494–497, 1996
  • Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818–821, 1992
  • Pinkel D, Segraves R, Sudar D, Clark S, Poole 1, Kowbel D, et al: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207–211, 1998
  • Shaffer LG, Bejjani BA: A cytogeneticist's perspective on genomic microarrays. Hum Reprod pdate 10:221–226, 2004
  • Knight SJ, Flint J: Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis. J Med Genet 37: 401–409, 2000
  • Schinzel A: Microdeletion syndromes, balanced transloca-tions, and gene mapping. J Med Genet 25:454 462, 1988
  • Shapira SK: An update on chromosome deletion and micro-deletion syndromes. Curr Opin Pediatr 10:622–627, 1998
  • McDonald-McGinn DM, Emanuel BS, Zackai EH: 22q11.2 deletion syndrome, GeneTests, http://www.genetests.org. Latest update July 23, 2003, University of Washington, Seattle. Copywrite 1997–2003
  • Knight SJ, Regan R, Nicod A, Horsley SW, Kearney L, Hom-fray T, et al: Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet 354:1676–1681, 1999
  • Debski RF, Rutledge JC, Kapur RP: A plea for the masses: a gross room approach to pediatric tumors. J Histotech 27:221–228, 2004
  • Brodeur GM: Neuroblastoma: biological insights into a clini-cal enigma. Nat Rev Cancer 3:203–216, 2003
  • Pui CH, Relling MV, Downing JR: Acute lymphoblastic leu-kemia. N Engl J Med 350:1535–1548, 2004
  • Brunning RD, Borowitz M, Matutes E, Head D, Flandrin G, Swerdlow SH, et al: Precursor B-cell and T-cell neoplasms, in World Health Organization Classification: Tumours of Hae-matopoietic and Lymphoid Tissues (Jaffe ES, et al, eds). IARC Press, Lyon, 2001, p 109–117
  • Loh ML, Rubnitz JE: TEL/AML 1-positive pediatric leukemia: prognostic significance and therapeutic approaches. Curt-Opin Hematol 9:345–352, 2002
  • McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, et al: TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leuke-mia. Blood 88:4252–4258, 1996
  • Rubnitz JE, Shuster JJ, Land VJ, Link MP, Pullen DJ, Camitta, BM, et al: Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lympho-blastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study. Blood 89:1143–1146, 1997
  • Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W, et al: Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 'chromosomal region. Lancet 359:1909–1915, 2002

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.